Matinas Biopharma Holdings Inc. Common Stock (MTNB)
Stock · AMEX · Health Care
$2.45as of 10/16/2026
Price chart
Active signals
MTNB Signal Track Record
How signals performed across all stocks →What MTNB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | -8.6% | 34% | July 24, 2026 |
| Bollinger Band Breakdown | 21 | -6.1% | 43% | September 15, 2026 |
| Bollinger Band Breakout | 19 | -8.4% | 37% | September 28, 2026 |
| 200-Day Moving Average TouchActive now | 5 | -10.6% | 20% | July 11, 2025 |
| Any 20-session window (baseline) | -6.0% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MTNB
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 2
- Website
- www.matinasbiopharma.com/
Fundamentals
- 1-day range
- $2.42$2.54
- Market cap
- $1.72M
- P/E (trailing)
- —
- P/E (forward)
- -0.81
- EPS (trailing)
- $-1.62
- Dividend yield
- —
- Beta
- 2.20
- Avg. volume
- 393.4K
How Matinas Biopharma Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2023 annual results
Source: 10-K filed Mar 27, 2024 · via SEC EDGAR / Finnhub
Matinas Biopharma Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MTNBMatinas Biopharma Holdings Inc. Common Stock$2.37▼ 2.07%Market cap $1.72MP/E —$2.26$28.95
- CMNDClearmind Medicine Inc. Common Shares$6.26▼ 2.49%Market cap $1.78MP/E —$5.25$3,840
- BFRGWBullfrog AI Holdings Inc. Warrants$0.13▲ 25.85%Market cap $2.04MP/E —$0.0751$0.6488
- SXTCChina SXT Pharmaceuticals Inc. Class A Ordinary Shares$0.065▼ 5.80%Market cap $2.06MP/E —$0.0619$83,758
- AZTRAzitra Inc Common Stock$0.072▲ 0.00%Market cap $2.18MP/E 6.22$0.0518$1.09
- GNPXGenprex Inc. Common Stock$2.11▼ 7.86%Market cap $2.24MP/E —$2.53$1,210
- PPBTPurple Biotech Ltd. American Depositary Shares$1.14▼ 7.32%Market cap $2.29MP/E —$1$2.2
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MTNB Matinas Biopharma Holdings Inc. Common Stock | $1.72M | — | $2.37 | ▼ 2.07% | $2.26$28.95 |
| CMND Clearmind Medicine Inc. Common Shares | $1.78M | — | $6.26 | ▼ 2.49% | $5.25$3,840 |
| BFRGW Bullfrog AI Holdings Inc. Warrants | $2.04M | — | $0.13 | ▲ 25.85% | $0.0751$0.6488 |
| SXTC China SXT Pharmaceuticals Inc. Class A Ordinary Shares | $2.06M | — | $0.065 | ▼ 5.80% | $0.0619$83,758 |
| AZTR Azitra Inc Common Stock | $2.18M | 6.22 | $0.072 | ▲ 0.00% | $0.0518$1.09 |
| GNPX Genprex Inc. Common Stock | $2.24M | — | $2.11 | ▼ 7.86% | $2.53$1,210 |
| PPBT Purple Biotech Ltd. American Depositary Shares | $2.29M | — | $1.14 | ▼ 7.32% | $1$2.2 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 10/5/2026
- Matinas BioPharma Board Approves 1-For-15 Reverse Stock Split Effective September 28, 2026Benzinga · 9/16/2026
- GH Power Signs Multi-Year Hydrogen Offtake Agreement with Change Energy for Hamilton Facility OutputYahoo · 9/14/2026
Insider Activity
Insider Actions →- Adam K. Stern · July 10, 2026 · X630.3K @ $0.35
- Adam K. Stern · July 10, 2026 · J141.5K @ $0.35
- Adam K. Stern · July 10, 2026 · Grant344.7K @ $0.35
- Adam K. Stern · July 10, 2026 · X344.7K @ $0.35
- Adam K. Stern · July 10, 2026 · Grant630.3K @ $0.35
- Sanitam Partners LLC · June 10, 2026 · J4.80M @ $0.6446
- Sanitam Partners LLC · June 10, 2026 · J1.4K @ $0.586
Institutional Ownership
March 31, 2026
- Total shares held
- 334.7K
- Total value held
- $167.5K
- Institutional holders
- 26
- Unknown65.2K
- Unknown51.7K
- Unknown49.6K
- Unknown40.1K
- Unknown32.5K
- Unknown28.6K
- Unknown20.7K
- Unknown15.3K
- Unknown14.3K
- Unknown12.7K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
MTNB Listed Among 12 Health Care Stocks Moving After-Market
Matinas Biopharma was included in a Benzinga list of 12 health care stocks that saw movement in Monday's after-market session. This indicates the stock experienced notable trading activity outside regular hours, likely due to recent developments or market sentiment. The company's stock has a wide 52-week range, reflecting its volatile nature.
MTNB Listed Among 12 Health Care Stocks Moving After-Market. Matinas Biopharma was included in a Benzinga list of 12 health care stocks that saw movement in Monday's after-market session. This indicates the stock experienced notable trading activity outside regular hours, likely due to recent developments or market sentiment. The company's stock has a wide 52-week range, reflecting its volatile nature.